RHYTHM PHARMACEUTICALS, INC. Operating Cash Flow
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Operating Cash Flow of -$53.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.15M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$44.19M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$25.39M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$26.62M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$115.67M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$113.88M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$136.16M.
- RHYTHM PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$173.43M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$53.34M 10-Q · filed 2026-08-04 | -$78.73M derived: sum of 3 quarters · filed 2026-08-04 | -$105.35M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$44.19M 10-Q · filed 2026-05-05 | -$69.57M derived: sum of 2 quarters · filed 2026-05-05 | -$96.20M derived: sum of 3 quarters · filed 2026-05-05 | -$119.51M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$25.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$52.01M derived: sum of 2 quarters · filed 2026-02-26 | -$75.32M derived: sum of 3 quarters · filed 2026-08-04 | -$115.67M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$26.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$49.94M derived: sum of 2 quarters · filed 2026-08-04 | -$90.29M 10-Q · filed 2025-11-04 | -$109.13M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$23.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$63.66M 10-Q · filed 2026-08-04 | -$82.51M derived: sum of 3 quarters · filed 2026-08-04 | -$107.72M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | -$40.35M 10-Q · filed 2026-05-05 | -$59.20M derived: sum of 2 quarters · filed 2026-05-05 | -$84.41M derived: sum of 3 quarters · filed 2026-05-05 | -$113.49M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$18.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$44.06M derived: sum of 2 quarters · filed 2026-02-26 | -$73.14M derived: sum of 3 quarters · filed 2026-02-26 | -$113.88M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$25.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$54.29M derived: sum of 2 quarters · filed 2025-11-04 | -$95.03M 10-Q · filed 2025-11-04 | -$124.42M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$29.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$69.82M 10-Q · filed 2025-08-05 | -$99.20M derived: sum of 3 quarters · filed 2026-02-26 | -$128.45M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$40.74M 10-Q · filed 2025-05-07 | -$70.13M derived: sum of 2 quarters · filed 2026-02-26 | -$99.38M derived: sum of 3 quarters · filed 2026-02-26 | -$140.47M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$29.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$58.63M derived: sum of 2 quarters · filed 2026-02-26 | -$99.72M derived: sum of 3 quarters · filed 2026-02-26 | -$136.16M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$29.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$70.34M derived: sum of 2 quarters · filed 2024-11-06 | -$106.77M 10-Q · filed 2024-11-06 | -$140.77M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | -$41.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$77.52M 10-Q · filed 2024-08-06 | -$111.52M derived: sum of 3 quarters · filed 2025-02-28 | -$158.51M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | -$36.43M 10-Q · filed 2024-05-07 | -$70.43M derived: sum of 2 quarters · filed 2025-02-28 | -$117.42M derived: sum of 3 quarters · filed 2025-02-28 | -$156.23M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | -$34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$80.99M derived: sum of 2 quarters · filed 2025-02-28 | -$119.80M derived: sum of 3 quarters · filed 2025-02-28 | -$173.43M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$46.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$85.80M derived: sum of 2 quarters · filed 2023-11-08 | -$139.43M 10-Q · filed 2023-11-08 | -$179.90M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$38.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$92.44M 10-Q · filed 2023-08-01 | -$132.91M derived: sum of 3 quarters · filed 2024-02-29 | -$173.07M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$53.63M 10-Q · filed 2023-05-02 | -$94.10M derived: sum of 2 quarters · filed 2024-02-29 | -$134.26M derived: sum of 3 quarters · filed 2024-02-29 | -$166.10M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$40.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$80.63M derived: sum of 2 quarters · filed 2024-02-29 | -$112.47M derived: sum of 3 quarters · filed 2024-02-29 | -$146.00M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$40.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$72.00M derived: sum of 2 quarters · filed 2022-11-08 | -$105.53M 10-Q · filed 2022-11-08 | -$134.65M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$31.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$65.37M 10-Q · filed 2022-08-03 | -$94.49M derived: sum of 3 quarters · filed 2023-03-01 | -$121.52M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$33.53M 10-Q · filed 2022-05-03 | -$62.65M derived: sum of 2 quarters · filed 2023-03-01 | -$89.68M derived: sum of 3 quarters · filed 2023-03-01 | -$119.41M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$29.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$56.15M derived: sum of 2 quarters · filed 2023-03-01 | -$85.88M derived: sum of 3 quarters · filed 2023-03-01 | -$121.98M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$27.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$56.76M derived: sum of 2 quarters · filed 2021-11-02 | -$92.86M 10-Q · filed 2021-11-02 | -$92.86M 10-Q · filed 2020-11-02 | -$125.08M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-06-30 | -$29.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$65.83M 10-Q · filed 2021-08-03 | -$98.05M derived: sum of 3 quarters · filed 2021-08-03 | -$131.65M derived: sum of 4 quarters · filed 2021-08-03 | ||
| 2020-03-31 | -$36.10M 10-Q · filed 2021-05-03 | -$68.32M derived: sum of 2 quarters · filed 2021-05-03 | -$101.92M derived: sum of 3 quarters · filed 2021-05-03 | -$127.47M derived: sum of 4 quarters · filed 2021-05-03 | ||
| 2019-12-31 | -$32.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$65.83M derived: sum of 2 quarters · filed 2021-03-01 | -$91.37M derived: sum of 3 quarters · filed 2021-03-01 | -$122.75M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | -$33.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$59.15M derived: sum of 2 quarters · filed 2020-11-02 | -$90.53M 10-Q · filed 2020-11-02 | -$111.51M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | -$25.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$56.92M 10-Q · filed 2020-08-03 | -$77.91M derived: sum of 3 quarters · filed 2021-03-01 | -$94.85M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$31.38M 10-Q · filed 2020-05-04 | -$52.36M derived: sum of 2 quarters · filed 2021-03-01 | -$69.30M derived: sum of 3 quarters · filed 2021-03-01 | -$81.78M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$20.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$37.92M derived: sum of 2 quarters · filed 2021-03-01 | -$50.41M derived: sum of 3 quarters · filed 2021-03-01 | -$62.06M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$16.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$29.42M derived: sum of 2 quarters · filed 2019-11-01 | -$41.07M 10-Q · filed 2019-11-01 | -$48.96M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$12.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | -$24.13M 10-Q · filed 2019-07-29 | -$32.02M derived: sum of 3 quarters · filed 2020-03-02 | -$40.43M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$11.65M 10-Q · filed 2019-05-03 | -$19.54M derived: sum of 2 quarters · filed 2020-03-02 | -$27.95M derived: sum of 3 quarters · filed 2020-03-02 | -$34.09M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$16.30M derived: sum of 2 quarters · filed 2020-03-02 | -$22.44M derived: sum of 3 quarters · filed 2020-03-02 | -$29.46M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$8.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$14.56M derived: sum of 2 quarters · filed 2018-11-09 | -$21.57M 10-Q · filed 2018-11-09 | -$27.75M derived: sum of 4 quarters · filed 2019-03-08 | ||
| 2017-06-30 | -$6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$13.16M 10-Q · filed 2018-08-08 | -$19.34M derived: sum of 3 quarters · filed 2019-03-08 | |||
| 2017-03-31 | -$7.02M 10-Q · filed 2018-05-14 | -$13.20M derived: sum of 2 quarters · filed 2019-03-08 | ||||
| 2016-12-31 | -$6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$23.22M 10-K · filed 2019-03-08 | ||||
| 2016-09-30 | -$17.04M 10-Q · filed 2017-11-14 | |||||
| 2015-12-31 | -$6.75M 8-K · filed 2018-11-09 | -$6.98M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |